162 related articles for article (PubMed ID: 11394458)
1. Results and side effects of high-intensity focused ultrasound in localized prostate cancer.
Chaussy C; Thüroff S
J Endourol; 2001 May; 15(4):437-40; discussion 447-8. PubMed ID: 11394458
[TBL] [Abstract][Full Text] [Related]
2. High-intensity focused ultrasound in prostate cancer: results after 3 years.
Chaussy C; Thüroff S
Mol Urol; 2000; 4(3):179-82. PubMed ID: 11062372
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of local prostatic carcinoma with high intensity focussed ultrasound (HIFU). Outcome and side-effects].
Thüroff S; Chaussy C
Urologe A; 2001 May; 40(3):191-4. PubMed ID: 11405127
[TBL] [Abstract][Full Text] [Related]
4. Local control of prostate cancer by transrectal HIFU-therapy.
Kiel HJ; Wieland WF; Rössler W
Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound].
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Souchon R; Blanc E; Cathignol D; Dubernard JM
Prog Urol; 1998 Feb; 8(1):68-77. PubMed ID: 9533155
[TBL] [Abstract][Full Text] [Related]
6. High-intensity focused ultrasound: complications and adverse events.
Thüroff S; Chaussy C
Mol Urol; 2000; 4(3):183-7;discussion 189. PubMed ID: 11062373
[TBL] [Abstract][Full Text] [Related]
7. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience.
Gelet A; Chapelon JY; Bouvier R; Souchon R; Pangaud C; Abdelrahim AF; Cathignol D; Dubernard JM
Eur Urol; 1996; 29(2):174-83. PubMed ID: 8647143
[TBL] [Abstract][Full Text] [Related]
8. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
9. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
10. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
11. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Lasne Y
J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389
[TBL] [Abstract][Full Text] [Related]
12. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
13. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
14. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
[TBL] [Abstract][Full Text] [Related]
15. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
[TBL] [Abstract][Full Text] [Related]
16. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
17. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
18. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
Urologiia; 2007; (6):39-44. PubMed ID: 18649659
[TBL] [Abstract][Full Text] [Related]
20. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.
Ficarra V; Antoniolli SZ; Novara G; Parisi A; Fracalanza S; Martignoni G; Artibani W
BJU Int; 2006 Dec; 98(6):1193-8. PubMed ID: 17125477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
